Bishal Gyawali
Bishal Gyawali/scri.queensu.ca

Bishal Gyawali: Surrogate Endpoints in Oncology-Opportunities, Pitfalls, and the Way Forward

Bishal Gyawali, Associate Professor at Queen’s University, shared a post on X by BG lab about a paper he co-authored on Science Direct:

“Everything you wanted to ask about surrogate endpoints but were afraid to ask.

Oncology BG Lab got you covered!”

Quoting BG Lab‘s post:

“Hi ESMO25, if you’re confused about all the surrogate endpoints used in different clinical trials and wondering how to make sense of them, we’ve got you covered. Read this paper from us, that covers almost everything you need to know about surrogates.”

Title: Frequently asked questions on surrogate endpoints in oncology-opportunities, pitfalls, and the way forward

Authors: Abhenil Mittal, Myung Sun Kim, Shenna Dunn, Kristin Wright, Bishal Gyawali.

Read the full article on Science Direct.

Bishal Gyawali: Surrogate Endpoints in Oncology-Opportunities, Pitfalls, and the Way Forward

You Can Also Read:

ESMO 2025 Day 1 Highlights Not to Miss

ESMO 2025 Day 2 Highlights Not to Miss

Bishal Gyawali: Surrogate Endpoints in Oncology-Opportunities, Pitfalls, and the Way Forward